Armed T cells with CAR for cancer immunotherapy

被引：0
|
作者：
Wei, Yu-Quan [1 ]
机构：
[1] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China
来源：
SCIENCE CHINA-LIFE SCIENCES | 2016年 / 59卷 / 04期
关键词：
EXPRESSION; CD19;
D O I：
10.1007/s11427-016-5047-0
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：331 / 332
页数：2
相关论文
共 50 条
  • [41] CAR γδ T cells for cancer immunotherapy. Is the field more yellow than green?
    Ganapathy, Thamizhselvi
    Radhakrishnan, Rajalingam
    Sakshi, Seth
    Martin, Sunil
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (02) : 277 - 286
  • [42] Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy
    Ramazan Rezaei
    Hadi Esmaeili Gouvarchin Ghaleh
    Mahdieh Farzanehpour
    Ruhollah Dorostkar
    Reza Ranjbar
    Masoumeh Bolandian
    Majid Mirzaei Nodooshan
    Akbar Ghorbani Alvanegh
    Cancer Gene Therapy, 2022, 29 : 647 - 660
  • [43] CAR-T cells for cancer immunotherapy-the barriers ahead and the paths through
    Zhang, Qiqi
    Zu, Cheng
    Hu, Yongxian
    Huang, He
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2022, 41 (06) : 567 - 581
  • [44] CAR γδ T cells for cancer immunotherapy. Is the field more yellow than green?
    Thamizhselvi Ganapathy
    Rajalingam Radhakrishnan
    Seth Sakshi
    Sunil Martin
    Cancer Immunology, Immunotherapy, 2023, 72 : 277 - 286
  • [45] Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy
    Rezaei, Ramazan
    Esmaeili Gouvarchin Ghaleh, Hadi
    Farzanehpour, Mahdieh
    Dorostkar, Ruhollah
    Ranjbar, Reza
    Bolandian, Masoumeh
    Mirzaei Nodooshan, Majid
    Ghorbani Alvanegh, Akbar
    CANCER GENE THERAPY, 2022, 29 (06) : 647 - 660
  • [46] Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives
    Coscia, Marta
    Vitale, Candida
    Cerrano, Marco
    Maffini, Enrico
    Giaccone, Luisa
    Bocca-Doro, Mario
    Bruno, Benedetto
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2019, 24 : 1284 - 1315
  • [47] Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
    Paula Salmikangas
    Niamh Kinsella
    Paul Chamberlain
    Pharmaceutical Research, 2018, 35
  • [48] Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy - Moving Target for Industry?
    Salmikangas, Paula
    Kinsella, Niamh
    Chamberlain, Paul
    PHARMACEUTICAL RESEARCH, 2018, 35 (08)
  • [49] γδ T cells in cancer immunotherapy
    Bukowski, JF
    BLOOD, 2003, 102 (01) : 4 - 4
  • [50] Cancer immunotherapy by γδ T cells
    Hayday, Adrian
    Dechanet-Merville, Julie
    Rossjohn, Jamie
    Silva-Santos, Bruno
    SCIENCE, 2024, 386 (6717)
12345